This is an auto-generated stub page built from atlas entry frontmatter. A richer
hand-crafted page is planned. See the
atlas source
for the full entry including detailed body sections.
nfe2l2
NRF2
NRF2 (NFE2L2) is the master antioxidant transcription factor sequestered by KEAP1; NFE2L2 gain-of-function mutations in ~15% of ESCC and ~15% of LUSC impair KEAP1 binding → constitutive NRF2 → chemotherapy/radiation resistance; no approved NRF2 inhibitor exists.
Entry Metadata
| Field | Value |
|---|---|
| ID | nfe2l2 |
| Name | NRF2 |
| Status | draft |
| Last reviewed | 2026-06-06 |
| Atlas | 01-human |
| Scale | 03-molecular |
Cross-Atlas Connections
Sources
- Shibata T, Kokubu A, Gotoh M, et al. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology. 2008;135(4):1358-1368. · PubMed 18692501
- Taguchi K, Yamamoto M. The KEAP1-NRF2 system in cancer. Front Oncol. 2017;7:85. · PubMed 28529921